| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $14.37 ▲ +1.15% | wingi | $14.14 ▼ -0.48% | Sesuk Adaptive Biotechnologies Corporation Common Stock (ADPT) persiyapan wis anchored kanggo $14.21 lan target $14.37 (+1.15%). Waca sing cedhak yaiku munggah; nonton $14.64 / $13.78 amarga volatilitas sing diwujudake saben dina babagan 5.93%. |
Sesuk Adaptive Biotechnologies Corporation Common Stock (ADPT) persiyapan wis anchored kanggo $14.21 lan target $14.37 (+1.15%). Waca sing cedhak yaiku munggah; nonton $14.64 / $13.78 amarga volatilitas sing diwujudake saben dina babagan 5.93%. | ||||
| Minggu | $14.72 ▲ +3.58% | Minggu kepungkur | $14.00 ▼ -1.50% | Model 7 dina Adaptive Biotechnologies Corporation Common Stock pindhah saka $14.00 menyang $14.72 (+3.58%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $14.64 / $13.78 prakara luwih saka siji obah. |
Model 7 dina Adaptive Biotechnologies Corporation Common Stock pindhah saka $14.00 menyang $14.72 (+3.58%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $14.64 / $13.78 prakara luwih saka siji obah. | ||||
| wulan | $15.29 ▲ +7.61% | Wulan kepungkur | $13.76 ▼ -3.20% | Target 1 wulan Adaptive Biotechnologies Corporation Common Stock yaiku $15.29 (+7.61%), dibandhingake karo referensi langsung ing cedhak $14.21. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Adaptive Biotechnologies Corporation Common Stock yaiku $15.29 (+7.61%), dibandhingake karo referensi langsung ing cedhak $14.21. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $16.15 ▲ +13.67% | Taun kepungkur | $13.39 ▼ -5.74% | Skenario 1 taun Adaptive Biotechnologies Corporation Common Stock nuduhake $16.15 (+13.67%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Adaptive Biotechnologies Corporation Common Stock nuduhake $16.15 (+13.67%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $18.17 ▲ +27.86% | 5 Taun kepungkur | $12.55 ▼ -11.70% | Tampilan 5 taun Adaptive Biotechnologies Corporation Common Stock yaiku $18.17 (+27.86%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Adaptive Biotechnologies Corporation Common Stock yaiku $18.17 (+27.86%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $14.21 | agêng |
| Ganti saben dina | -2.54% | Ngisor |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 63% | Ndhuwur |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $14.21 | Ganti saben dina | -2.54% |
| Pasar Kab | $2.19B | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.